Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-057118

Director sold 21,161 shares at an average $50.09 ($1,059,956)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Prokupets Elena Director 2021-09-17 Sale −5,152 $50.04 $257,808 48,024 I: show line 1 in the form
Prokupets Elena Director 2021-09-17 Sale −5,688 $50.05 $284,687 531,697 I: show line 2 in the form
Prokupets Elena Director 2021-09-21 Sale −4,988 $50.13 $250,051 43,036 I: show line 3 in the form
Prokupets Elena Director 2021-09-21 Sale −5,333 $50.14 $267,410 526,364 I: show line 4 in the form
Open-market sales · 21,161 sh · avg $50.09 · $1,059,956
Loading xslF345X03/doc4.xml…